GSD NovaType Select L452R SARS-CoV-2 (1x96)

GSD NovaType Select L452R SARS-CoV-2 (1x96)

GSD NovaPrime® Plus SARS-CoV-2 (1x96)

GSD NovaPrime® Plus SARS-CoV-2 (1x96)

GSD NovaType Select L452R SARS-CoV-2 (4x96)

New Singleplex RT-PCR assay for the detection of the mutation L452R occurring with SARS-CoV-2 variants of concern or variants of interestor variants under monitoring B.1.617.2 (Delta), B.1.427 / B.1.429 (Epsilon), B.1.617.1 (Kappa), B.1.617.3, and B.1.526.1 (Iota).

For Research Use Only.

Not available in the US.

The GSD NovaType Select L452R SARS-CoV-2 is a research use only (RUO) real-time reverse transcription PCR (RT-PCR) Singleplex assay designed for the qualitative detection of the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) S gene mutation L452R. Sample material should be genomic RNA extracted from human upper respiratory (nasal wash/smear, nasopharyngeal wash/smear, oropharyngeal swab) specimen types that have previously tested positive for SARS-CoV-2 RNA by diagnostic RT-PCR methods e.g. GSD NovaPrime® SARS-CoV-2 (COVID-19).

Key Benefits

• Confirmatory test for the detection of the mutation L452R

• Kit Contents: RT-PCR Enzyme Mix, Primer-Probe-Mix, Positive Control, Nuclease Free Water

• Specimen types: nasal wash/smear, nasopharyngeal wash/smear, oropharyngeal swab

• Validated PCR platforms: AriaMxTM and AriaDxTM (Agilent Technologies)

 

The GSD NovaType Select L452R SARS-CoV-2 is expressly not intended for diagnosis of SARS-CoV-2 infection and not for use in diagnostic procedures. It is only designed to aid investigations related to the prevalence and frequency of virus variants.

 

More Information
SKU PCOVL452R4
No. of tests 4 x 96
Specificity Mutation L452R in SARS-CoV-2 variants
PCR cycler platforms AriaMxTM and AriaDxTM (Agilent Technologies)
Kit components RT-PCR Enzyme Mix, Primer-Probe-Mix, Positive Control, Nuclease Free Water

Test Instructions